Text

<h2 style="white-space:pre-line;text-align:center">New iPS Cell Lines in Development</h2>
<p style="text-align:center">Welcome to our Pipeline section, where we highlight newly generated iPSC lines currently under development and characterization. This includes both patient-derived and HLA-selected lines, as well as ongoing efforts to produce differentiated derivatives such as cardiomyocytes, neurons, and organoids. This page is regularly updated to reflect our latest progress and future additions to the Saudi iPSC Bank.</p>

KAIMRC iPS Cell Bank

We want to establish a website for our medical center that offers iPS lines obtained through cellular reprogramming of blood cells as a commercial product, which can be used by pharmaceutical or biotechnology companies as well as academic research institutions for studying disease mechanisms and screening drugs.